Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 3,672 $ 3,791
Trade receivables 321 79
Other accounts receivable and prepaid expenses 750 270
Restricted deposit 12 12
Inventory 730 888
Total current assets 5,485 5,040
Non-current assets:    
Restricted deposit 167 168
Operating lease right-of-use assets 3,048 3,215
Property and equipment, net 2,248 2,329
Total non-current assets 5,463 5,712
Total assets 10,948 10,752
Current liabilities:    
Loan 12 24
Accounts payable:    
Trade payables 559 833
Accrued liabilities and other 866 1,203
Operating lease liabilities 442 455
Deferred revenues 297 942
Total current liabilities 2,176 3,457
Non-current liabilities:    
Derivatives 42 68
Operating lease liabilities 2,953 3,139
Total non-current liabilities 2,995 3,207
Total liabilities 5,171 6,664
Commitments and contingencies
Shareholders' Equity:    
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of June 30, 2020 and December 31, 2019; issued and outstanding: 6,467,536 and 5,670,829 ordinary shares as of June 30, 2020 and December 31, 2019, respectively 2,713 2,368
Additional paid in capital and warrants 74,865 69,949
Currency translation differences (969) (969)
Accumulated deficit (70,832) (67,260)
Total shareholders' equity 5,777 4,088
Total liabilities and shareholders' equity $ 10,948 $ 10,752